Cheryl Heiner

USPTO Granted Patents = 34 (Patent Applications = 6)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 10)

Average Co-Inventor Count = 5.7

ph-index = 15

Forward Citations = 900(Granted Patents)

Location History:

San Mateo, CA (US) (2011 - 2016)
Menlo Park, CA (US) (2016)
La Honda, CA (US) (2003 - 2023)

Company Filing History:

22 out of 432

Pacific Biosciences of California, Inc.

Applied Biosystems, LLC

patents

4. 1 out of 647

The UAB Research Foundation (The University of Alabama at Birmingham)

patents

Years Active: 2003-2025

Loading Chart...

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12473596 - Delaying real-time sequencing (2025-11-18),

2. 11844666 - Classification of nucleic acid templates (2023-12-19),

3. 11705217 - Sequencing using concatemers of copies of sense and antisense strands (2023-07-18),

4. 11629376 - Delaying real-time sequencing (2023-04-18),

5. 11155865 - Systems and methods for genetic and biological analysis (2021-10-26),

6. 11021748 - Systems and methods for genetic and biological analysis (2021-06-01),

7. 10793903 - Identifying organisms in a sample using sequencing kinetic signatures (2020-10-06),

8. 10787705 - Systems and methods for genetic and biological analysis (2020-09-29),

9. 10612091 - Systems and methods for genetic and biological analysis (2020-04-07),

10. 10494672 - Systems and methods for genetic and biological analysis (2019-12-03),

11. 10294523 - Identification of nucleic acid template-linked barcodes comprising nucleic acid modifications (2019-05-21),

12. 10266892 - Systems and methods for genetic and biological analysis (2019-04-23),

13. 10260095 - Systems and methods for genetic and biological analysis (2019-04-16),

14. 10081836 - Delaying real-time sequencing (2018-09-25),

15. 9951383 - Methods of sequencing and identifying the position of a modified base in a nucleic acid (2018-04-24),

Title: Cheryl Heiner - Pioneering Innovations in Nucleic Acid Sequencing

Introduction:

Cheryl Heiner, a brilliant inventor based in La Honda, CA (US), has made significant contributions to the field of nucleic acid sequencing with a remarkable portfolio of 33 patents. Her groundbreaking work in the characterization of modified nucleic acids has revolutionized the way we understand and analyze genetic information.

Latest Patents:

Heiner's latest patents showcase her expertise in single molecule sequencing methods for identifying modified nucleotides within nucleic acid sequences. One patent focuses on the classification of nucleic acid templates, enabling the detection of various modifications such as chemically modified bases, enzymatically modified bases, and non-natural bases. Another patent introduces sequencing using concatemers of copies of sense and antisense strands, providing a method for obtaining a single molecule consensus sequence for a template molecule.

Career Highlights:

Throughout her career, Cheryl Heiner has been associated with reputable companies at the forefront of biotechnology innovation. She has made significant contributions to companies such as Pacific Biosciences of California, Inc. and Genapsys, Inc., where her expertise in nucleic acid sequencing has been instrumental in advancing research and development efforts.

Collaborations:

Heiner's impactful work in the field of nucleic acid sequencing has been fueled by collaborations with talented individuals in the industry. Some of her notable coworkers include Kevin Travers and Stephen Wilson Turner, who have worked alongside Heiner to drive forward pioneering research that is shaping the future of genetic analysis.

Conclusion:

Cheryl Heiner's remarkable achievements in the realm of nucleic acid sequencing underscore her ingenuity and dedication to advancing scientific knowledge. Her impressive patent portfolio and collaborative efforts with industry experts have solidified her reputation as a trailblazer in the field. With her innovative approach and commitment to excellence, Cheryl Heiner continues to push the boundaries of genetic research and inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.